scholarly journals OA05.03 Single-Agent Rovalpituzumab Tesirine, a Delta-Like Protein 3 (DLL3)-Targeted Antibody-Drug Conjugate (ADC), in Small-Cell Lung Cancer (SCLC)

2017 ◽  
Vol 12 (1) ◽  
pp. S260-S261
Author(s):  
David Spigel ◽  
M Catherine Pietanza ◽  
Todd Bauer ◽  
Neal Ready ◽  
Daniel Morgensztern ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Single Agent ◽  
Small Cell ◽  
Small Cell Lung ◽  
Antibody Drug Conjugate ◽  
Drug Conjugate ◽  
Antibody Drug

scholarly journals A GPC2 antibody-drug conjugate is efficacious against neuroblastoma and small-cell lung cancer via binding a conformational epitope

2021 ◽  
Vol 2 (7) ◽  
pp. 100344
Author(s):  
Swetha Raman ◽  
Samantha N. Buongervino ◽  
Maria V. Lane ◽  
Doncho V. Zhelev ◽  
Zhongyu Zhu ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Conformational Epitope ◽  
Small Cell ◽  
Small Cell Lung ◽  
Antibody Drug Conjugate ◽  
Drug Conjugate ◽  
Antibody Drug
Sign in / Sign up

Export Citation Format

Share Document